The 10-day moving average for CNMD crossed bearishly below the 50-day moving average on September 18, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 81%.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CNMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
CNMD broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for CNMD entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CNMD's RSI Oscillator exited the oversold zone, 27 of 42 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 64%.
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on CNMD as a result. In 54 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 63%.
The Moving Average Convergence Divergence (MACD) for CNMD just turned positive on October 15, 2026. Looking at past instances where CNMD's MACD turned positive, the stock continued to rise in 32 of 46 cases over the following month. The odds of a continued upward trend are 70%.
CNMD moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +2.54% 3-day Advance, the price is estimated to grow further. Considering data from situations where CNMD advanced for three days, in 202 of 295 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.
The Tickeron PE Growth Rating for this company is 5 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. CNMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 62 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.416) is normal, around the industry mean (2.906). P/E Ratio (26.622) is within average values for comparable stocks, (2.003). Projected Growth (PEG Ratio) (0.010) is also within normal values, averaging (11.052). Dividend Yield (0.016) settles around the average of (0.009) among similar stocks. P/S Ratio (1.055) is also within normal values, averaging (40.124).
The Tickeron SMR rating for this company is 81 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CNMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
The Aroon Indicator for IRTC entered a downward trend on October 15, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 170 similar instances where the Aroon Indicator formed such a pattern. In 149 of the 170 cases the stock moved lower. This puts the odds of a downward move at 88%.
The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IRTC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
IRTC broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Momentum Indicator moved above the 0 level on October 19, 2026. You may want to consider a long position or call options on IRTC as a result. In 71 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.
The Moving Average Convergence Divergence (MACD) for IRTC just turned positive on October 15, 2026. Looking at past instances where IRTC's MACD turned positive, the stock continued to rise in 38 of 49 cases over the following month. The odds of a continued upward trend are 78%.
IRTC moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +6.80% 3-day Advance, the price is estimated to grow further. Considering data from situations where IRTC advanced for three days, in 256 of 324 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
The Tickeron Valuation Rating of 3 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: IRTC's P/B Ratio (21.493) is slightly higher than the industry average of (2.906). IRTC's P/E Ratio (-288.738) is considerably lower than the industry average of (2.003). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (4.398) is also within normal values, averaging (40.124).
The Tickeron Seasonality Score of 23 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 49 (best 1 - 100 worst), indicating steady price growth. IRTC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 53 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 64 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
CNMD | IRTC | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 62 Fair valued | 3 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 64 | |
SMR RATING 1..100 | 81 | 93 | |
PRICE GROWTH RATING 1..100 | 41 | 49 | |
P/E GROWTH RATING 1..100 | 5 | 53 | |
SEASONALITY SCORE 1..100 | 85 | 23 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
IRTC's Valuation (3) in the Medical Specialties industry is somewhat better than the same rating for CNMD (62). This means that IRTC’s stock grew somewhat faster than CNMD’s over the last 12 months.
IRTC's Profit vs Risk Rating (64) in the Medical Specialties industry is somewhat better than the same rating for CNMD (100). This means that IRTC’s stock grew somewhat faster than CNMD’s over the last 12 months.
CNMD's SMR Rating (81) in the Medical Specialties industry is in the same range as IRTC (93). This means that CNMD’s stock grew similarly to IRTC’s over the last 12 months.
CNMD's Price Growth Rating (41) in the Medical Specialties industry is in the same range as IRTC (49). This means that CNMD’s stock grew similarly to IRTC’s over the last 12 months.
CNMD's P/E Growth Rating (5) in the Medical Specialties industry is somewhat better than the same rating for IRTC (53). This means that CNMD’s stock grew somewhat faster than IRTC’s over the last 12 months.
| CNMD | IRTC | |
|---|---|---|
| RSI ODDS (%) | 5 days ago 64% | 4 days ago 88% |
| Stochastic ODDS (%) | 4 days ago 76% | 4 days ago 74% |
| Momentum ODDS (%) | 4 days ago 63% | 4 days ago 82% |
| MACD ODDS (%) | 4 days ago 70% | 4 days ago 78% |
| TrendWeek ODDS (%) | 4 days ago 65% | 4 days ago 78% |
| TrendMonth ODDS (%) | 4 days ago 63% | 4 days ago 80% |
| Advances ODDS (%) | 14 days ago 68% | 4 days ago 79% |
| Declines ODDS (%) | 8 days ago 81% | 19 days ago 80% |
| BollingerBands ODDS (%) | 4 days ago 65% | 4 days ago 73% |
| Aroon ODDS (%) | 4 days ago 72% | 4 days ago 88% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CNMD’s FA Score shows that 1 FA rating(s) are green while IRTC’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CNMD’s TA Score shows that 5 TA indicator(s) are bullish while IRTC’s TA Score has 4 bullish TA indicator(s).
CNMD (@Medical/Nursing Services) experienced а +5.42% price change this week, while IRTC (@Medical/Nursing Services) price change was +11.60% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +6.78%. For the same industry, the average monthly price growth was -3.44%, and the average quarterly price growth was +0.72%.
CNMD is expected to report earnings on Oct 28, 2026.
IRTC is expected to report earnings on Nov 05, 2026.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
A.I.dvisor indicates that over the last year, CNMD has been loosely correlated with NVST. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if CNMD jumps, then NVST could also see price increases.
| Ticker / NAME | Correlation To CNMD | 1D Price Change % | ||
|---|---|---|---|---|
| CNMD | 100% | -0.38% | ||
| NVST - CNMD | 49% Loosely correlated | -1.54% | ||
| KIDS - CNMD | 49% Loosely correlated | -0.85% | ||
| IART - CNMD | 48% Loosely correlated | -3.37% | ||
| ENOV - CNMD | 47% Loosely correlated | -2.36% | ||
| ZBH - CNMD | 46% Loosely correlated | -0.25% | ||
More | ||||
A.I.dvisor indicates that over the last year, IRTC has been loosely correlated with STE. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if IRTC jumps, then STE could also see price increases.
| Ticker / NAME | Correlation To IRTC | 1D Price Change % | ||
|---|---|---|---|---|
| IRTC | 100% | +1.36% | ||
| STE - IRTC | 45% Loosely correlated | -0.03% | ||
| GEHC - IRTC | 41% Loosely correlated | +0.10% | ||
| INGN - IRTC | 39% Loosely correlated | +0.85% | ||
| SYK - IRTC | 39% Loosely correlated | +0.02% | ||
| CNMD - IRTC | 38% Loosely correlated | -0.38% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| KOMP | 62.60 | 0.32 | +0.51% |
| State Street SPDR S&P Kensho New Economies Composite ETF (KOMP) | |||
| VCLN | 25.74 | N/A | N/A |
| Virtus Duff & Phelps Clean Energy ETF (VCLN) | |||
| MTRA | 25.81 | N/A | N/A |
| Invesco International Growth Focus ETF (MTRA) | |||
| PBAP | 31.72 | -0.02 | -0.06% |
| PGIM S&P 500 Buffer 20 ETF - April (PBAP) | |||
| FSCC | 33.64 | -0.14 | -0.41% |
| Federated Hermes MDT Small Cap Core ETF (FSCC) | |||